CORC

在结果中检索

CORC

浏览/检索结果: 共14条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
A camptothecin-based, albumin-binding prodrug enhances efficacy and safety in vivo 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 226, 页码: 11
作者:  Cheng, Zhiyang;  Huang, Ying;  Shen, Qianqian;  Zhao, Yangrong;  Wang, Lei
收藏  |  浏览/下载：87/0  |  提交时间：2021/11/04
Development of Taccalonolide AJ-Hydroxypropyl-beta-Cyclodextrin Inclusion Complexes for Treatment of Clear Cell Renal-Cell Carcinoma 期刊论文
MOLECULES, 2020, 卷号: 25, 期号: 23, 页码: 14
作者:  Han, Jing;  Zhang, Siwang;  Niu, Junxin;  Zhang, Chunli;  Dai, Weichen
收藏  |  浏览/下载：30/0  |  提交时间：2021/05/24
Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2020, 卷号: 32, 期号: 3, 页码: 370-+
作者:  Li, Huiping;  Liu, Rongrui;  Shao, Bin;  Ran, Ran;  Song, Guohong
收藏  |  浏览/下载：23/0  |  提交时间：2020/12/24
The role of critical micellization concentration in efficacy and toxicity of supramolecular polymers 期刊论文
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 卷号: 117, 期号: 9, 页码: 4518-4526
作者:  Su, Hao;  Wang, Feihu;  Ran, Wei;  Zhang, Weijie;  Dai, Wenbing
收藏  |  浏览/下载：30/0  |  提交时间：2020/07/01
Self-assembling mertansine prodrug improves tolerability and efficacy of chemotherapy against metastatic triple-negative breast cancer 期刊论文
JOURNAL OF CONTROLLED RELEASE, 2020, 卷号: 318, 页码: 234-245
作者:  Ran, Wei;  Liu, Xiaoyu;  Chang, Lu;  Cai, Ying;  Zheng, Chao
收藏  |  浏览/下载：23/0  |  提交时间：2020/07/01
Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers 期刊论文
FRONTIERS IN PHARMACOLOGY, 2018, 卷号: 9
作者:  Li, Xiaojiao;  Liu, Ca;  Zhu, Xiaoxue;  Wei, Haijing;  Zhang, Hong
收藏  |  浏览/下载：60/0  |  提交时间：2019/01/08
Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy Individuals 期刊论文
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 卷号: 121, 期号: 5, 页码: 414-422
作者:  Zheng, Li;  Liang, Mao-zhi;  Zeng, Xiao-ling;  Li, Cai-zheng;  Zhang, Yi-fan
收藏  |  浏览/下载：30/0  |  提交时间：2019/01/08
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 卷号: 9
作者:  Sun, Yongkun;  Niu, Wei;  Du, Feng;  Du, Chunxia;  Li, Shuting
收藏  |  浏览/下载：40/0  |  提交时间：2019/01/08
A phase I study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 卷号: 7
作者:  Zhang, Jian;  Cao, Junning;  Li, Jin;  Zhang, Yifan;  Chen, Zhiyu
收藏  |  浏览/下载：19/0  |  提交时间：2019/01/08
Reflections on the Bridging Methods in the Early Exploratory General Toxicology Study 期刊论文
Chinese Pharmaceutical Journal, 2013, 卷号: 48, 期号: 21, 页码: 1785-1788
作者:  Liu Yongzhen;  Gong Likun;  Ren Jin
收藏  |  浏览/下载：11/0  |  提交时间：2019/01/08

©版权所有 ©2017 CSpace - Powered by CSpace